WDNA vs. IDNA
WDNA (WisdomTree BioRevolution Fund) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds - WDNA tracks the WisdomTree BioRevolution Index while IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index. Both are passively managed. Over the past 5 years, WDNA returned -5.03%/yr vs -8.18%/yr for IDNA. Their correlation of 0.90 suggests significant overlap in exposure. WDNA charges 0.45%/yr vs 0.47%/yr for IDNA.
Performance
WDNA vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WDNA achieves a 13.32% return, which is significantly lower than IDNA's 19.52% return.
WDNA
- 1D
- 0.49%
- 1M
- 8.93%
- YTD
- 13.32%
- 6M
- 11.11%
- 1Y
- 50.90%
- 3Y*
- 5.47%
- 5Y*
- -5.03%
- 10Y*
- —
IDNA
- 1D
- 1.53%
- 1M
- 6.29%
- YTD
- 19.52%
- 6M
- 16.84%
- 1Y
- 54.42%
- 3Y*
- 11.16%
- 5Y*
- -8.18%
- 10Y*
- —
WDNA vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
WDNA WisdomTree BioRevolution Fund | 13.32% | 22.68% | -14.18% | -2.07% | -26.29% | -4.92% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 19.52% | 17.26% | -0.72% | -7.63% | -42.28% | -5.50% |
Correlation
The correlation between WDNA and IDNA is 0.89, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.89 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.89 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.91 |
Correlation (All Time) Calculated using the full available price history since Jun 3, 2021 | 0.90 |
The correlation between WDNA and IDNA has been stable across timeframes, ranging from 0.89 to 0.91 - a consistent structural relationship.
WDNA vs. IDNA - Sectors Allocation Comparison
Sectors
WDNA
IDNA
Healthcare
Basic Materials
-
Consumer Defensive
-
Energy
-
Communication Services
-
-
Consumer Cyclical
-
-
Financial Services
-
-
Industrials
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
WDNA
IDNA
Basic Materials
WDNA
IDNA
-
Consumer Defensive
WDNA
IDNA
-
Energy
WDNA
IDNA
-
Communication Services
WDNA
-
IDNA
-
Consumer Cyclical
WDNA
-
IDNA
-
Financial Services
WDNA
-
IDNA
-
Industrials
WDNA
-
IDNA
Real Estate
WDNA
-
IDNA
-
Technology
WDNA
-
IDNA
-
Utilities
WDNA
-
IDNA
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WDNA vs. IDNA — Risk / Return Rank
WDNA
IDNA
WDNA vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| WDNA | IDNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.22 | ||
| Sortino ratioReturn per unit of downside risk | -0.22 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.34 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 4.37 | 5.13 | -0.75 |
| Martin ratioReturn relative to average drawdown | 9.80 | 14.30 | -4.50 |
Loading charts...
Drawdowns
WDNA vs. IDNA - Drawdown Comparison
The maximum WDNA drawdown since its inception was -58.87%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for WDNA and IDNA.
Loading charts...
Drawdown Indicators
| WDNA | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.87% | -68.26% | +9.39% |
Max Drawdown (1Y)Largest decline over 1 year | -11.70% | -10.66% | -1.04% |
Max Drawdown (3Y)Largest decline over 3 years | -38.25% | -29.46% | -8.79% |
Max Drawdown (5Y)Largest decline over 5 years | -58.87% | -68.26% | +9.39% |
Current DrawdownCurrent decline from peak | -27.05% | -41.07% | +14.02% |
Average DrawdownAverage peak-to-trough decline | -35.56% | -36.28% | +0.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.21% | 3.82% | +1.39% |
Volatility
WDNA vs. IDNA - Volatility Comparison
WisdomTree BioRevolution Fund (WDNA) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) have volatilities of 7.39% and 7.33%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WDNA | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.39% | 7.33% | +0.06% |
Volatility (6M)Calculated over the trailing 6-month period | 16.98% | 18.45% | -1.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.90% | 24.96% | +0.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.14% | 28.47% | -3.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.06% | 29.51% | -4.45% |
WDNA vs. IDNA - Expense Ratio Comparison
WDNA has a 0.45% expense ratio, which is lower than IDNA's 0.47% expense ratio.
Dividends
WDNA vs. IDNA - Dividend Comparison
WDNA's dividend yield for the trailing twelve months is around 4.03%, more than IDNA's 0.90% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 0.90% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
WDNA WisdomTree BioRevolution Fund | 4.03% | 4.57% | 0.75% | 0.80% | 0.38% | 0.10% | 0.00% | 0.00% |
Frequently Asked Questions
WDNA and IDNA have a correlation of 0.89, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
WDNA has higher volatility (7.39%) compared to IDNA (7.33%). In terms of maximum drawdown, WDNA dropped -58.87% vs IDNA's -68.26%.
On 5-year performance, WDNA leads with -5.03% vs -8.18% for IDNA. On fees, WDNA is cheaper at 0.45% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, WDNA has performed better with a -5.03% return vs -8.18%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
WDNA is cheaper with a 0.45% expense ratio, compared with 0.47% for IDNA.
WDNA has the higher dividend yield at 4.03%, compared with 0.90% for IDNA.
WDNA tracks WisdomTree BioRevolution Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: WisdomTree and iShares. Their fees differ too: 0.45% for WDNA and 0.47% for IDNA.
IDNA currently has the higher Sharpe Ratio (2.19 vs 1.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for WDNA and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer